Literature DB >> 7937521

The cutoff time point of the partial area method for assessment of rate of absorption in bioequivalence studies.

P Macheras1, M Symillides, C Reppas.   

Abstract

The partial area method has been suggested for the assessment of the absorption rate in bioequivalence studies. This paper provides a theoretical basis for the estimation of the optimal cutoff time point of the partial areas for drugs with one compartment model disposition. The analysis is performed by using the appropriate equations which relate the normalized (in terms of the extent of absorption) partial areas with time expressed in terms of multiples of half-life. Provided that the quality of experimental data ensures precise estimation of the parameters, the tmax of the formulation with the faster absorption characteristics is generally the most practical cutoff time point for calculation of the normalized partial areas, when a drug follows one compartment model disposition with linear absorption.

Mesh:

Year:  1994        PMID: 7937521     DOI: 10.1023/a:1018921622981

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  4 in total

1.  An alternative approach for assessment of rate of absorption in bioequivalence studies.

Authors:  M L Chen
Journal:  Pharm Res       Date:  1992-11       Impact factor: 4.200

2.  Cmax/AUC is a clearer measure than Cmax for absorption rates in investigations of bioequivalence.

Authors:  L Endrenyi; S Fritsch; W Yan
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1991-10

3.  Evaluation of different indirect measures of rate of drug absorption in comparative pharmacokinetic studies.

Authors:  L F Lacey; O N Keene; C Duquesnoy; A Bye
Journal:  J Pharm Sci       Date:  1994-02       Impact factor: 3.534

4.  Estimation of absorption rate constant in a one-compartment model with the profile of the bioavailable dose eliminated as a function of multiples of half-life.

Authors:  P Macheras; M Symillides; C Reppas
Journal:  J Pharm Sci       Date:  1993-12       Impact factor: 3.534

  4 in total
  7 in total

1.  Evaluation of truncated areas in the assessment of bioequivalence of immediate release formulations of drugs with long half-lives and of Cmax with different dissolution rates.

Authors:  P Sathe; J Venitz; L Lesko
Journal:  Pharm Res       Date:  1999-06       Impact factor: 4.200

Review 2.  Measures of exposure versus measures of rate and extent of absorption.

Authors:  M L Chen; L Lesko; R L Williams
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

3.  An in vitro methodology for forecasting luminal concentrations and precipitation of highly permeable lipophilic weak bases in the fasted upper small intestine.

Authors:  Dimitrios Psachoulias; Maria Vertzoni; James Butler; David Busby; Moira Symillides; Jennifer Dressman; Christos Reppas
Journal:  Pharm Res       Date:  2012-08-14       Impact factor: 4.200

Review 4.  Using partial area for evaluation of bioavailability and bioequivalence.

Authors:  Mei-Ling Chen; Barbara Davit; Robert Lionberger; Zakaria Wahba; Hae-Young Ahn; Lawrence X Yu
Journal:  Pharm Res       Date:  2011-04-13       Impact factor: 4.200

5.  The duration of measuring partial AUCs for the assessment of bioequivalence.

Authors:  L Endrenyi; F Csizmadia; L Tothfalusi; A H Balch; M L Chen
Journal:  Pharm Res       Date:  1998-03       Impact factor: 4.200

Review 6.  Metrics for the evaluation of bioequivalence of modified-release formulations.

Authors:  Laszlo Endrenyi; Laszlo Tothfalusi
Journal:  AAPS J       Date:  2012-08-22       Impact factor: 4.009

7.  Use of partial AUC (PAUC) to evaluate bioequivalence--a case study with complex absorption: methylphenidate.

Authors:  Jeanne Fourie Zirkelbach; Andre J Jackson; Yaning Wang; Donald J Schuirmann
Journal:  Pharm Res       Date:  2012-09-25       Impact factor: 4.200

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.